본문 바로가기

Effect of Red Ginseng on Genotoxicity and Health-Related Quality of Life after Adjuvant Chemotherapy in Patients with Epithelial Ovarian Cancer: A Randomized, Double Blind, Placebo-Controlled Trial

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q2Scopus Q1
저널
NUTRIENTS9(7) · 2017
피인용
Web of Science 51Scopus 55
FWCI (Scopus)
2.38
JCR IF
JCR 2016 3.55
ISSN
2072-6643

저자

  1. Kim, Hee Seung제1저자Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea
  2. Kim, Mi-KyungDepartment of Obstetrics and Gynecology, Cheil General Hospital & Women’s Healthcare Center, Dankook University College of Medicine, Seoul, South Korea
  3. Lee, MariaDepartment of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea
  4. 권병수Department of Obstetrics and Gynecology, Pusan National University School of Medicine, Busan, South Korea
  5. Suh, Dong HoonDepartment of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, South Korea
  6. Song, Yong Sang교신저자Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea

초록

We evaluated the effect of red ginseng on toxicity, health-related quality of life (HRQL) and survival after adjuvant chemotherapy in patients with epithelial ovarian cancer (EOC). A total of 30 patients with EOC were randomly assigned to placebo (n = 15) and red ginseng groups (n = 15). All patients took placebo or red ginseng (3000 mg/day) for three months. Then, we compared changes of genotoxicity, HRQL and survival between the two groups. As a result, red ginseng reduced micronuclei yield in comparison with placebo despite no difference of binucleated cells index. Although red ginseng increased serum levels of alanine aminotransferase and aspartate aminotransferase significantly, they were within the normal value. Moreover, there were no differences in adverse events between placebo and red ginseng groups. In terms of HRQL, red ginseng was associated with improved emotional functioning and decreased symptoms of fatigue, nausea and vomiting, and dyspnea, reduced anxiety and interference affecting life and improved daytime somnolence. However, there was no effect of red ginseng on prognosis of EOC. Conclusively, red ginseng may be safe and effective to reduce genotoxicity and improve HRQL despite no benefit of survival in patients with EOC who received chemotherapy.

키워드

red ginsengtoxicityhealth-related quality of lifechemotherapyepithelial ovarian cancerPERIPHERAL-BLOOD LYMPHOCYTESKOREAN VERSIONPANAX-GINSENGCHINESE MEDICINEOXIDATIVE STRESSCLINICAL-TRIALVALIDATIONSURVIVALFATIGUEDAMAGE

식별자

Scopus EID
2-s2.0-85025650229
WoS UID
000406679700128